Diaceutics (LON:DXRX) Receives Buy Rating from Canaccord Genuity Group

Canaccord Genuity Group restated their buy rating on shares of Diaceutics (LON:DXRXFree Report) in a research note published on Tuesday, Marketbeat Ratings reports. They currently have a GBX 150 ($1.91) target price on the stock.

Diaceutics Stock Up 3.8 %

DXRX stock opened at GBX 123 ($1.56) on Tuesday. The company’s 50-day moving average price is GBX 103.54 and its 200 day moving average price is GBX 96.47. The company has a market cap of £104.16 million, a P/E ratio of 10,500.00 and a beta of 0.47. Diaceutics has a 52 week low of GBX 79 ($1.00) and a 52 week high of GBX 125 ($1.59). The company has a current ratio of 7.99, a quick ratio of 9.92 and a debt-to-equity ratio of 3.07.

Insider Activity at Diaceutics

In other Diaceutics news, insider Peter Keeling sold 750,000 shares of the stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of GBX 102 ($1.30), for a total transaction of £765,000 ($972,292.83). In other Diaceutics news, insider Graham Paterson bought 33,564 shares of the business’s stock in a transaction dated Wednesday, March 6th. The shares were acquired at an average price of GBX 99 ($1.26) per share, with a total value of £33,228.36 ($42,232.28). Also, insider Peter Keeling sold 750,000 shares of the firm’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of GBX 102 ($1.30), for a total transaction of £765,000 ($972,292.83). Insiders own 34.54% of the company’s stock.

Diaceutics Company Profile

(Get Free Report)

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.

Featured Articles

Receive News & Ratings for Diaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diaceutics and related companies with MarketBeat.com's FREE daily email newsletter.